Table 2:
% Methylated CpG RU1 |
Change in % methylated CpG per RUa |
|||||
---|---|---|---|---|---|---|
Subject ID | Chromosome | Length D4Z4 | Intercept | 90% CI | Slope | 90% CI |
| ||||||
FSHD1 | ||||||
P6 | chr4qA-S | 3U | 14.2 | 10.6 – 17.7 | 0 | −2.1 – 2.1 |
P1 | chr4qA-S | 6U | 10.3 | 7.3 – 13.2 | 2.8 | 2.3 – 3.4 |
P2 | chr4qA-S | 6U | 15.3 | 12.0 – 18.5 | 2.1 | 1.5 – 2.8 |
P3 | chr4qA-S | 6U | 11.5 | 8.6 – 14.5 | 2.3 | 1.8 – 2.8 |
P4 | chr4qA-S | 6U | 10.4 | 7.2 – 13.7 | 2.9 | 2.3 – 3.5 |
P5 | chr4qA-S | 9U | 10.1 | 5.6 – 14.5 | 2 | 1.3 – 2.7 |
P5 | chr4qA-L | 9U | 18 | 12.8 – 23.2 | 2.3 | 1.4 – 3.1 |
P3 | chr10q | 9U | 24.9 | 21.5 – 28.3 | 2.3 | 1.7 – 2.8 |
P1 | chr10q | 11U | 17.4 | 15.1 – 19.7 | 2.2 | 1.9 – 2.6 |
P1 | chr10q | 13U | 25.4 | 22.0 – 28.8 | 1.9 | 1.3 – 2.4 |
P1, P2, P3, P4, P5, P6 | chr4qA-S | >10U, centromeric | 46.6 | 42.5 – 50.7 | 6.1 | 5.3 – 6.8 |
P1, P2, P3, P4, P5, P6 | chr4qA-S | >10U, telomeric | 76.2 | 72.1 – 80.3 | −1 | −1.6 – −0.3 |
FSHD2 | ||||||
P7 | chr10q | 8U | 9.5 | 6.5 – 12.5 | 1.2 | 0.7 – 1.7 |
P8 | chr10q | 10U | 11.9 | 8.6 – 15.2 | 0.7 | 0.2 – 1.3 |
P7 | chr10q | 12U | 11.8 | 8.4 – 15.3 | 0.8 | 0.2 – 1.3 |
P8 | chr4qA-S | 16U | 13.3 | 8.4 – 18.2 | 0.5 | −0.3 – 1.2 |
P7 | chr4qA-S | 19U | 14.4 | 7.0 – 21.8 | 0.6 | −0.5 – 1.7 |
Unaffected Control | ||||||
C4 | chr4qB | 16U, prox 6U | 33.7 | 30.4 – 37.0 | 6.2 | 5.6 – 6.8 |
C4 | chr4qB | 16U, distal 6U | 64.1 | 60.7 – 67.4 | −1.3 | −1.9 – −0.7 |
C4 | chr10q | 20U, prox 6U | 29.4 | 25.9 – 33.0 | 5.7 | 5.1 – 6.4 |
C4 | chr10q | 20U, distal 6U | 71.4 | 67.9 – 74.9 | −0.5 | −1.2 – 0.1 |
C4 | chr10q | 21U, prox 6U | 34.5 | 31.0 – 37.9 | 5.7 | 5.1 – 6.4 |
C4 | chr10q | 21U, distal 6U | 77.1 | 73.5 – 80.6 | −0.9 | −1.6 – −0.2 |
C4 | chr4qA-L | 42U, prox 6U | 42.5 | 38.4 – 46.6 | 7.1 | 6.3 – 7.9 |
C4 | chr4qA-L | 42U, distal 6U | 89.8 | 86.3 – 93.4 | −1 | −1.6 – −0.4 |
RU-repeat unit